CLChengxi Li

Chengxi Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chengxi Li has a total of 91 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Phosphonium Relay for Integrated Cleavage‐to‐Cyclization of Cyclic Peptides

    by Xin He, Xing‐Xing Yang, Pei Xie, Zhu‐Yuan Liu, Cheng‐Xi Li

    Head‐to‐tail macrocyclization of peptides is typically performed through stepwise workflows that separate resin cleavage, isolation of linear intermediates, and subsequent cyclization, largely due to incompatible activation requirements for each transformation. Here we report a phosphonium‐mediated relay that unifies these steps within a single activation node. In this design, an electrophile‐activated phosphonium species promotes cleavage from standard 2‐chlorotrityl chloride (2‐CTC) resin and is proposed to enable in situ formation of a C ‐terminally activated intermediate for intramolecular amidation. The strategy directly couples cleavage to cyclization on standard peptide supports without auxiliary linkers, intermediate purification, or high‐dilution cyclization conditions. The method is compatible with diverse peptide sequccnces and functional handles and can be integrated into a closed‐loop automated workflow for end‐to‐end synthesis, with advantages for hydrophobic substrates by avoiding isolation of poorly soluble linear intermediates such as Vespid chemotactic peptide 5f . Process‐level benchmarking against side‐chain anchoring further demonstrated favorable process metrics and gram‐scale scalability. This work establishes a linker‐free cleavage‐to‐cyclization strategy and provides a practical framework for integrated and automation‐compatible cyclic peptide synthesis.

  • A Phosphonium Relay for Integrated Cleavage‐to‐Cyclization of Cyclic Peptides

    by Xin He, Xing‐Xing Yang, Pei Xie, Zhu‐Yuan Liu, Cheng‐Xi Li

    Head‐to‐tail macrocyclization of peptides is typically performed through stepwise workflows that separate resin cleavage, isolation of linear intermediates, and subsequent cyclization, largely due to incompatible activation requirements for each transformation. Here we report a phosphonium‐mediated relay that unifies these steps within a single activation node. In this design, an electrophile‐activated phosphonium species promotes cleavage from standard 2‐chlorotrityl chloride (2‐CTC) resin and is proposed to enable in situ formation of a C ‐terminally activated intermediate for intramolecular amidation. The strategy directly couples cleavage to cyclization on standard peptide supports without auxiliary linkers, intermediate purification, or high‐dilution cyclization conditions. The method is compatible with diverse peptide sequccnces and functional handles and can be integrated into a closed‐loop automated workflow for end‐to‐end synthesis, with advantages for hydrophobic substrates by avoiding isolation of poorly soluble linear intermediates such as Vespid chemotactic peptide 5f . Process‐level benchmarking against side‐chain anchoring further demonstrated favorable process metrics and gram‐scale scalability. This work establishes a linker‐free cleavage‐to‐cyclization strategy and provides a practical framework for integrated and automation‐compatible cyclic peptide synthesis.

  • Open Access

    Linker-Encoded Enzymatic Topology Control Enables Automated Peptide Stapling with Reusable Immobilized mTGase

    by Wanglin Zhan, Cheng Fan, Chengrui Hu, Chengxi Li

    Microbial transglutaminase (mTGase) readily forms intermolecular isopeptide bonds, but this native bias promotes peptide oligomerization at synthetically useful concentrations. Here we encode reaction topology in a minimal diamine linker to redirect mTGase toward intramolecular stapling of unprotected glutamine-containing peptides. Direct comparison with a linker-free Lys–Gln substrate shows that the linker-encoded architecture maintains macrocyclization as the dominant pathway from 0.25 to 2.0 mM, whereas the native substrate undergoes exclusively intermolecular ligation. Linker and peptide studies establish geometric, electronic, and sequence requirements, and molecular simulations are consistent with the organization of the acyl–enzyme intermediate. The resulting staples serve as versatile synthetic handles for orthogonal bicyclization, late-stage functionalization, and reductive ring opening. The covalent immobilization of mTGase enables catalyst recycling and seamless integration into a continuous, automated peptide-stapling platform capable of processing diverse substrates. This linker-encoded strategy provides a route to control enzymatic reaction topology for programmable constrained-peptide synthesis.

  • Open Access

    Secondary-Amine Relay Enables Lysine-Directed Multicomponent Functionalization of Peptides

    by Cheng Ren, Mengyao Zhang, Tiefeng Jiang, Feng Wan, Yicheng Lv, Lin Yang, Chengxi Li

    Multicomponent reactions provide powerful modularity for peptide functionalization, but their application to lysine residues remains limited by the low efficiency of direct primary-amine-based activation pathways under peptide-compatible conditions. Here we report a secondary-amine relay strategy for lysine-directed multicomponent functionalization of peptides. In this approach, salicylaldehyde derivatives, arylboronic acids, and a cyclic secondary amine are combined to generate a transient electrophilic intermediate, which is subsequently intercepted by the ε-amine of lysine-containing peptides. By separating electrophile generation from direct lysine activation, this relay protocol improves the efficiency of lysine modification while retaining the modularity of multicomponent chemistry. Mechanistic experiments, isolated intermediate studies, kinetic comparisons, and density functional theory calculations support a pathway involving secondary-amine-mediated intermediate formation followed by lysine capture. The method enables modification of diverse bioactive peptides, incorporation of drug-derived and fluorescent aldehyde or boronic acid components, and lysine–lysine stapling using bifunctional aldehydes. The reaction is further compatible with automated and parallel solid-phase peptide modification workflows, providing rapid access to libraries of lysine-functionalized peptide conjugates. This study provides a practical secondary-amine relay platform for modular peptide functionalization and expands the utility of multicomponent chemistry in automated peptide synthesis.

  • SuFEx-Enabled Acyl Fluoride Chemistry for High-Concentration Minimal-Oligomerization Peptide Macrocyclization

    by Yuhan Zhao, Pei Xie, Tongkun Wang, Feng Wan, Cheng Fan, Xiao-Song Xue, Chengxi Li

    Head-to-tail macrocyclization is a cornerstone transformation in cyclic peptide synthesis, yet its practical implementation remains constrained by extensive oligomerization under concentrated conditions. Here we report a SuFEx-enabled acyl fluoride activation strategy that intrinsically biases peptide macrocyclization toward intramolecular amide bond formation, enabling highly selective head-to-tail cyclization at concentrations up to 100 mM. In contrast to conventional uronium- and phosphonium-based coupling reagents, which generate complex oligomeric mixtures under identical conditions, the SuFEx-derived acyl fluoride pathway consistently affords cyclic monomers with minimal dimerization across diverse peptide sequences. Density functional theory calculations reveal that acyl fluoride activation reshapes the macrocyclization energy landscape by favoring irreversible ring closure while disfavoring oligomer growth, providing a mechanistic basis for the observed chemoselectivity. The method exhibits broad substrate scope, tolerating variations in ring size, sequence composition, and functionalized residues, and is readily translated to solid-phase and automated synthesis platforms. These results establish SuFEx-enabled acyl fluoride activation as a fundamentally distinct and practically robust solution to peptide macrocyclization under high-concentration conditions.


  • A Modular PMDA Linker Enables Lysine-Selective Cyclization of Unprotected Peptides and Automated Macrocycle Assembly

    by Jiashu Wu, Wanglin Zhan, Xingxing Yang, Chengxi Li, Qiwei Yang, Zongbi Bao, Qilong Ren, Zhiguo Zhang

    Macrocyclic peptide stapling is a powerful strategy to enhance conformational stability and functional performance, yet existing approaches often suffer from limited chemoselectivity, constrained modularity, or poor compatibility with automated synthesis. Here we report a pyromellitic dianhydride (PMDA)-based Lys-Lys stapling platform that enables highly chemoselective intramolecular bis-amidation of fully unprotected peptides under mild conditions. Distinct from conventional bifunctional linkers, PMDA operates as a tetrafunctional scaffold, simultaneously inducing efficient macrocyclization while installing two carboxylate handles for downstream diversification. The reaction exhibits exceptional selectivity for lysine ε-amines, tolerating all other nucleophilic side chains, including cysteine, across a broad range of peptide sequences and linker spacings. The resulting macrocycles support stepwise bicyclization and modular postcyclization conjugation with nucleic acids, small-molecule drugs, and affinity tags. Application to antimicrobial peptides demonstrates enhanced conformational constraint and markedly improved proteolytic stability. Importantly, the chemistry is intrinsically compatible with solid-phase peptide synthesis and fully integrated, end-to-end automated workflows without hardware modification. This PMDA-mediated stapling strategy establishes a versatile, automation-ready linker platform for rapid assembly and functional diversification of macrocyclic peptides.


  • SPECTRAL: An Intelligent and Ultra‐Sensitive Photonic Hydrogel Platform for Biomarker‐Based Cancer Prediction

    by Junjie Qin, Xingxing Yang, Jia Guo, Chengrui Hu, Shao Q. Yao, Chengxi Li

    Point‐of‐care (POC) biosensing holds great promise for noninvasive cancer diagnostics, as circulating tumor DNA (ctDNA) serves as a minimally invasive biomarker for early detection. However, effective ctDNA detection remains challenging due to low abundance and complex workflows. Herein, we present SPECTRAL (Smart Photonic‐hydrogel Enhanced chip for Cancer Type Recognition and AnaLysis), a sequencing‐free platform integrating photonic‐crystal hydrogels with charge‐neutral peptide nucleic acid (PNA) probes for efficient volumetric signal transduction and single‐nucleotide discrimination. Photonic‐crystal‐enhanced fluorescence amplifies signals of fluorescently labeled recombinase polymerase amplification (RPA) amplicons, achieving a detection limit of 100 copies per µL, with substantially improved sensitivity over conventional fluorescence assays. A single SPECTRAL chip simultaneously profiles 205 ctDNA mutations and eight protein biomarkers from plasma samples. The PNA sensor library is generated via an automated synthesis system guided by machine learning (ML)‐predicted probe difficulty. Multimodal signals are analyzed using cloud‐based ML to classify multiple cancer types (lung, breast, and colorectal), achieving 90.0% specificity and 86.7% sensitivity (87.5% overall accuracy) within 100 min from sample to diagnosis, based on validation with patient plasma samples. By combining molecular biosensing, photonic signal amplification, and AI‐driven analysis, SPECTRAL provides a low‐instrument‐dependent platform for decentralized liquid‐biopsy cancer diagnostics.

  • SPECTRAL: An Intelligent and Ultra‐Sensitive Photonic Hydrogel Platform for Biomarker‐Based Cancer Prediction

    by Junjie Qin, Xingxing Yang, Jia Guo, Chengrui Hu, Shao Q. Yao, Chengxi Li

    Point‐of‐care (POC) biosensing holds great promise for noninvasive cancer diagnostics, as circulating tumor DNA (ctDNA) serves as a minimally invasive biomarker for early detection. However, effective ctDNA detection remains challenging due to low abundance and complex workflows. Herein, we present SPECTRAL (Smart Photonic‐hydrogel Enhanced chip for Cancer Type Recognition and AnaLysis), a sequencing‐free platform integrating photonic‐crystal hydrogels with charge‐neutral peptide nucleic acid (PNA) probes for efficient volumetric signal transduction and single‐nucleotide discrimination. Photonic‐crystal‐enhanced fluorescence amplifies signals of fluorescently labeled recombinase polymerase amplification (RPA) amplicons, achieving a detection limit of 100 copies per µL, with substantially improved sensitivity over conventional fluorescence assays. A single SPECTRAL chip simultaneously profiles 205 ctDNA mutations and eight protein biomarkers from plasma samples. The PNA sensor library is generated via an automated synthesis system guided by machine learning (ML)‐predicted probe difficulty. Multimodal signals are analyzed using cloud‐based ML to classify multiple cancer types (lung, breast, and colorectal), achieving 90.0% specificity and 86.7% sensitivity (87.5% overall accuracy) within 100 min from sample to diagnosis, based on validation with patient plasma samples. By combining molecular biosensing, photonic signal amplification, and AI‐driven analysis, SPECTRAL provides a low‐instrument‐dependent platform for decentralized liquid‐biopsy cancer diagnostics.


  • Open Access

    CycloPepper: a machine learning platform for predicting cyclization outcomes and optimizing synthesis of therapeutic cyclopeptides

    by Yourong Pan, Chengrui Hu, Jiaqi Li, Feng Wan, Xin Hong, Chengxi Li

    Cyclic peptides exhibit remarkable stability, membrane permeability, and binding affinity, positioning them as promising therapeutics. However, their synthesis, particularly on-resin head-to-tail cyclization, remains challenging, with cyclization site selection critically influencing yield. Here, we introduce a machine learning (ML) approach to predict cyclization outcomes, leveraging CycloBot, our fully automated cyclic peptide synthesis platform. Using this system, we generate a standardized dataset of 306 cyclic peptides (2–14 residues) and develop an ML model achieving an average prediction accuracy of 84%. Experimental validation with 74 random and therapeutic peptides showed an 86% prediction consistency. To facilitate practical use, we built CycloPepper, a user-friendly platform available through both web and software interfaces, enabling rapid cyclization site assessment. This tool effectively identified potential cyclization sites for disease-targeting peptides, including cancer biomarkers. Our work illustrates the potential of ML-assisted synthesis to streamline cyclic peptide synthesis and accelerate therapeutic discovery.